4//SEC Filing
Vollins James 4
Accession 0001103021-22-000017
CIK 0001103021other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:57 PM ET
Size
19.4 KB
Accession
0001103021-22-000017
Insider Transaction Report
Form 4
Vollins James
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-01-31+8,303→ 24,579 total - Exercise/Conversion
Common Stock
2022-01-31+3,834→ 28,413 total - Exercise/Conversion
Restricted Stock Units
2022-01-29−8,303→ 8,303 totalExercise: $0.00Exp: 2023-01-29→ Common Stock (8,303 underlying) - Award
Restricted Stock Units
2022-01-27+50,546→ 50,546 totalExercise: $0.00Exp: 2025-01-27→ Common Stock (50,546 underlying) - Exercise/Conversion
Restricted Stock Units
2022-01-31−3,834→ 0 totalExercise: $0.00Exp: 2022-01-31→ Common Stock (3,834 underlying) - Exercise/Conversion
Restricted Stock Units
2022-01-27−16,276→ 32,552 totalExercise: $0.00Exp: 2024-01-27→ Common Stock (16,276 underlying) - Award
Stock Options (right to buy)
2022-01-27+282,055→ 282,055 totalExercise: $3.66Exp: 2032-01-26→ Common Stock (282,055 underlying) - Exercise/Conversion
Common Stock
2022-01-27+16,276→ 16,276 total
Footnotes (7)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
- [F2]The stock options were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
- [F3]The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
- [F4]Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.
- [F5]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 27, 2021, under the Plan. The remaining RSUs vest in equal portions on: (i) January 27, 2023; and (ii) January 27, 2024.
- [F6]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 29, 2020, under the Issuer's 2019 Plan. The remaining RSUs vest on January 29, 2023.
- [F7]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 31, 2019, under the Issuer's 2011 Equity Incentive Plan, as amended.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001757833
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:57 PM ET
- Size
- 19.4 KB